LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Copeland Capital Management LLC

Copeland Capital Management LLC lowered its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 8.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,078,723 shares of the medical instruments supplier's stock after selling 93,292 shares during the quarter. LeMaitre Vascular makes up about 1.8% of Copeland Capital Management LLC's investment portfolio, making the stock its 7th largest position. Copeland Capital Management LLC owned approximately 4.78% of LeMaitre Vascular worth $90,505,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in LMAT. Principal Financial Group Inc. raised its position in shares of LeMaitre Vascular by 3.8% during the fourth quarter. Principal Financial Group Inc. now owns 108,617 shares of the medical instruments supplier's stock worth $10,008,000 after acquiring an additional 3,942 shares during the last quarter. Sanctuary Advisors LLC raised its position in shares of LeMaitre Vascular by 6.0% during the fourth quarter. Sanctuary Advisors LLC now owns 2,065 shares of the medical instruments supplier's stock worth $207,000 after acquiring an additional 117 shares during the last quarter. Truist Financial Corp raised its position in shares of LeMaitre Vascular by 21.0% during the fourth quarter. Truist Financial Corp now owns 8,923 shares of the medical instruments supplier's stock worth $822,000 after acquiring an additional 1,547 shares during the last quarter. Illinois Municipal Retirement Fund raised its position in shares of LeMaitre Vascular by 6.7% during the fourth quarter. Illinois Municipal Retirement Fund now owns 11,507 shares of the medical instruments supplier's stock worth $1,060,000 after acquiring an additional 725 shares during the last quarter. Finally, Illumine Investment Management LLC bought a new stake in shares of LeMaitre Vascular during the fourth quarter worth $1,238,000. Institutional investors own 84.64% of the company's stock.

Insider Buying and Selling

In other LeMaitre Vascular news, CEO George W. Lemaitre sold 4,399 shares of the business's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $85.10, for a total value of $374,354.90. Following the completion of the transaction, the chief executive officer now directly owns 1,827,003 shares of the company's stock, valued at approximately $155,477,955.30. The trade was a 0.24% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 100,000 shares of company stock valued at $8,556,857 over the last three months. Company insiders own 9.50% of the company's stock.

LeMaitre Vascular Trading Up 0.2%

Shares of LMAT stock traded up $0.17 on Friday, reaching $82.57. 230,472 shares of the stock were exchanged, compared to its average volume of 170,069. The stock has a market cap of $1.87 billion, a PE ratio of 41.70, a P/E/G ratio of 2.18 and a beta of 0.83. LeMaitre Vascular, Inc. has a one year low of $71.42 and a one year high of $109.58. The company has a debt-to-equity ratio of 0.48, a current ratio of 16.49 and a quick ratio of 13.83. The stock has a 50 day moving average price of $83.66 and a 200 day moving average price of $88.69.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $0.48 EPS for the quarter, missing analysts' consensus estimates of $0.50 by ($0.02). LeMaitre Vascular had a return on equity of 13.53% and a net margin of 19.96%. The company had revenue of $59.87 million for the quarter, compared to analyst estimates of $57.61 million. During the same period last year, the firm earned $0.44 earnings per share. The firm's revenue for the quarter was up 12.0% on a year-over-year basis. Equities research analysts forecast that LeMaitre Vascular, Inc. will post 1.94 EPS for the current fiscal year.

LeMaitre Vascular Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were paid a dividend of $0.20 per share. The ex-dividend date was Thursday, May 15th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.97%. LeMaitre Vascular's dividend payout ratio (DPR) is presently 40.40%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.